Literature DB >> 16368719

Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway.

Junetsu Ogasawara1, Minori Sanpei, Nazibur Rahman, Tomonobu Sakurai, Takako Kizaki, Yoshiaki Hitomi, Hideki Ohno, Tetsuya Izawa.   

Abstract

The effect of exercise on beta-adrenergic receptor (beta-AR) trafficking was investigated in rat adipocytes. The binding sites of a hydrophilic ligand, [(3)H]CGP12177, increased immediately (0 h) and at 3 h after exercise (3 h) but decreased at 24 h after exercise (24 h). The data of immunoblotting revealed that the alterations in the binding sites mainly paralleled the alterations in the beta2-AR proteins in membrane fractions. The protein expressions of both G-protein-coupled receptor kinase (GRK)-2 and beta-arrestin-2 were reduced, with a decline in beta2-AR ubiquitination at 0 h and 3 h. The protein expressions of beta2-AR, GRK-2, beta-arrestin-2, the beta2-AR/beta-arrestin-2 complex, and beta2-AR ubiquitination returned to their respective control levels at 24 h, whereas the beta2-AR mRNA level was reduced. Administration of either lactacystin or propranolol did not alter GRK-2 and beta2-AR protein expressions after exercise. Thus, the mechanism underlying the increased density of beta2-AR up to at least 3 h may involve alterations in a multistep event involving the coordinate interaction among proteins mediating beta2-AR trafficking, in which both the receptor-agonist interactions and ubiquitin-proteasome pathway have a key role. However, the decreased protein expression of beta2-AR at 24 h might be due to some change occurring at the translational levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368719     DOI: 10.1096/fj.05-4688fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.

Authors:  Ping Wang; Yong Jiang; Yinsheng Wang; John Y Shyy; Kathryn A DeFea
Journal:  BMC Biochem       Date:  2010-09-21       Impact factor: 4.059

2.  Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2.

Authors:  Takako Kizaki; Tetsuya Izawa; Takuya Sakurai; Shukoh Haga; Naoyuki Taniguchi; Hisao Tajiri; Kenji Watanabe; Noorbibi K Day; Kenji Toba; Hideki Ohno
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

Review 3.  Muscle plasticity and β₂-adrenergic receptors: adaptive responses of β₂-adrenergic receptor expression to muscle hypertrophy and atrophy.

Authors:  Shogo Sato; Ken Shirato; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Biomed Biotechnol       Date:  2011-11-15

4.  Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes.

Authors:  Junetsu Ogasawara; Takuya Sakurai; Takako Kizaki; Yoshinaga Ishibashi; Tetsuya Izawa; Yoshikazu Sumitani; Hitoshi Ishida; Zsolt Radak; Shukoh Haga; Hideki Ohno
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 5.  The Molecular Mechanism Underlying Continuous Exercise Training-Induced Adaptive Changes of Lipolysis in White Adipose Cells.

Authors:  Junetsu Ogasawara; Tetsuya Izawa; Tomonobu Sakurai; Takuya Sakurai; Ken Shirato; Yoshinaga Ishibashi; Hitoshi Ishida; Hideki Ohno; Takako Kizaki
Journal:  J Obes       Date:  2015-05-13

6.  Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1.

Authors:  Qian Hu; Jiali Hu; Cuiyu Chen; Yang Wang; Yu Zhang; Jielin Wan; Ouyang Jing; Hanying Yi; Shiyu Wang; Weihua Huang; Jie Liu; Wei Zhang; Howard L McLeod; Ran Xu; Yijing He
Journal:  Transl Androl Urol       Date:  2022-08

7.  Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Immun Ageing       Date:  2013-03-15       Impact factor: 6.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.